PTEN-deficient cells have previously been found to exhibit resistance to rapamycin in advanced transitional cell carcinoma, the most frequently diagnosed type of bladder cancer [36], suggesting a protective role of PTEN in bladder cancer. This evidence concerns the gene PTEN and urinary bladder carcinoma.